Northwest Biotherapeutics Inc
NWBO· OTC
NWBONorthwest Biotherapeutics Inc
Filed May 21, 2012 · 10-Q · 51 days after period end · 0001144204-12-030833
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Revenue | $0.00 | $0.00 |
| Net Income | -$10.15M | -$8.41M |
| EPS Diluted | -$1.06 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Northwest Biotherapeutics Inc · CIK 1072379 · Engraved from SEC EDGAR
ended Mar 31, 2012 · filed May 21, 2012 · 51 d after period end
